Please Note: This trial is no longer enrolling new participants
Phase 1 study of venetoclax/azacitidine or venetoclax in combination with ziftomenib (KO-539) or standard induction cytarabine/daunorubicin (7+3) chemotherapy in combination with ziftomenib for the treatment of patients with acute myeloid leukemia
Protocol No. | CTO-KO-MEN-007 | Scope | National |
---|---|---|---|
Principal Investigator | Hamid Sayar | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase I |